Syrian Arab Republic

2 Vaccines Approved for Use in Syrian Arab Republic

Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: tass.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
3 trials in 1 country
Approval Source: emro.who.int